Metastatic uveal melanoma. Prophylaxis and treatment;Aderhautmelanom. Adjuvante therapie bei hochrisikopatienten und neue therapieansätze im metastasierten stadium

Ophthalmologe

Volumn 99, Issue 5, 2002, Pages 333-337

  Bechrakis, Nikolaos E ^a   Scheibenbogen, C ^a   Schmittel, A ^a   Servetopoulou, F ^a   Foerster, M H ^a   Keilholz, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemotherapy; Metastasis; Prognosis; Uveal melanoma; Vaccination

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DACARBAZINE; FOTEMUSTINE; GEMCITABINE; IBUPROFEN; INTERLEUKIN 2; PACLITAXEL; TREOSULFAN; TUMOR ANTIGEN; TUMOR VACCINE; VINCA ALKALOID;

ADVANCED CANCER; ARTIFICIAL EMBOLISM; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; HUMAN; METASTASIS; PROGNOSIS; PROPHYLAXIS; REVIEW; SURVIVAL TIME; TREATMENT OUTCOME; UVEA MELANOMA; VACCINATION;

EID: 0346034751     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-002-0634-9     Document Type: Review

References (30)

1. (2001) Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 119:670-676
2. Agarwala S, Glaspy J, O'Day SJ, et al. (2002) Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma. J Clin Oncol 20:125-133
3. Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC (2000) A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Clin Cancer Res 6:3062-3070
4. Augsburger JJ, Correa ZM, Freire J, Brady LW (1998) Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy. Ophthalmology 105:1670-1678
5. Bedikian AY, Kantarjian H, Young SE, Bodey GP (1981) Prognosis in metastatic choroidal melanoma. South Med J 74:574-577
6. Bedikian AY, Legha SS, Mavligit G et al. (1995) Treatment of uveal melanoma metastatic to the liver: a review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 76:1665-1670
7. Diener-West M, Earle JD, Fine SL et al. (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 119:969-982
8. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP (1992) A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following en ucleation, 1966 through 1988. Arch Ophthalmol 110:245-250
9. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM (1988) Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32:239-251
10. Egerer G, Lehnert T, Max R, Naeher H, Keilholz U, Ho AD (2001) Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients. Int J Clin Oncol 6:25-28
11. Egger E, Schalenbourg A, Zografos L, Bercher L, Boehringer T, Chamot L, Goitein G (2001) Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 51:138-147
12. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T (2000) Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 107:1443-1449
13. Eskelin S, Pyrhonen S, Summanen P, Prause JU, Kivela T (1999) Screening for metastatic malignant melanoma of the uvea revisited. Cancer 85:1151-1159
14. Flaherty LE, Unger JM, Liu PY, Mertens WC, Sondak VK (1998) Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. Am J Clin Oncol 21:568-572
15. Fuchs E (1882) Das Sarcom des Uvealtractus. Braunmüller, Wien
16. Gorich J, Hasan I, Sittek H et al. (1995) Side effects and complications of intra-arterial tumor therapy - experiences with 577 interventions. Röntgenpraxis 48:132-145
17. Gragoudas ES, Egan KM, Seddon JM et al. (1991) Survival of patients with metastases from uveal melanoma. Ophthalmology 98:383-389; discussion 390
18. Gragoudas ES, Seddon JM, Egan KM et al. (1988) Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology 95:992-999
19. Jaeger E, Ringhoffer M, Dienes H et al. (1996) GM-CSF enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer 67:54-62
20. Keilholz U, Scheibenbogen C, Foerster MH et al. (2001) Phase I tudy in high-risk melanoma patients of adjuvant vaccination with MHC class I binding tyrosinase peptides comparing various immunological adjuvants. J Mol Med 97:36a
21. Keilholz U, Schmitel A, Scheulen ME et al. (2001) Gemcitabine and treosulfan (GeT): a chemotherapy combination with activity in a variety of frequently resistant neoplasms. Onkologie 24:112
22. Leyvraz S, Spataro V, Bauer J et al. (1997) Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 15:2589-2595
23. Lommatzsch PK, Werschnik C, Schuster E (2000) Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol 238:129-137
24. Marchand M, van Baren N, Weynants P et al. (1999) Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 80:219-230
25. Neale MH, Myatt NE, Khoury GG et al. (2001) Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Res 11:601-609
26. Pyrhonen S (1998) The treatment of metastatic uveal melanoma. Eur J Cancer 34 [Suppl 3]:S27-30
27. Scheibenbogen C, Schmittel A, Keilholz U et al. (2000) Phase 2 trial of vaccination with tyrosinase prptides and granulocyte-maxrophage colony-stimulating factor in patients with metastatic melanoma. J Immunother 23:275-281
28. Shields JA, Augsburger JJ, Donoso LA, Bernardino VB Jr, Portenar M (1985) Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol 100:666-668
29. Singh AD (2001) Uveal melanoma: implications of tumor doubling time. Ophthalmology 108:829-830
30. Valmori D, Scheibenbogen C, Dutoit V et al. (in press) Circulating tumor-reactive CD8+ T cells in melanoma patients contain a CD45RA+CCR7- effector subset exerting ex-vivo tumor-specific cytolytic activity. Cancer Res